Abiopharma

🔍 MADDOCK ERNEST E (Director)

Company: TERADYNE, INC (TER)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 2 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,597.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Represents deferred stock units ("DSUs") issued to the Reporting Person in accordance with his election to receive dividends paid on DSUs in the form of additional DSUs in lieu of cash. Such acquisition is exempt under Exchange Act Rule 16b-3(d). DSUs are settled one-for-one in Common Stock generally within ninety days of the date as of which a non-employee director no longer serves in such capacity.